CytoReason uses AI to transform biopharma decisions, mapping diseases with extensive data to guide research, compare drugs, and optimize drug portfolios.

Content Locked
Login or Register a FREE account to continue browsing our content
2016
Tel Aviv, Israel
Israel

51 - 200
Series B| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Register for our free weekly newsletter
Stay up to date with the latest news, special reports, videos, infobytes, and features on the region's most notable entrepreneurial ecosystems